Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
TV & Film
Health & Fitness
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts124/v4/f7/00/80/f70080dc-f58a-d571-7184-f6aa56fc535a/mza_8875933359820743369.jpg/600x600bb.jpg
Health Law Diagnosed
Mintz
7 episodes
2 months ago
In the latest episode of Health Law Diagnosed, host Bridgette Keller discusses the new Massachusetts Health Care Market Review Law and what this means for health care providers, investors, and other key stakeholders. She is joined by Member Deborah Daccord, Of Counsel, Cassie Paolillo, and Of Counsel Kate Stewart, who share their insights on the law’s far-reaching implications, including: 1. An overview of the Massachusetts Health Care Review Law and its implications 2. Key takeaways for health care entities 3. Upcoming HPC guidance and how it will affect health care transactions 4. Expanded oversight and new authorities for Massachusetts health care agencies 5. Financial assessments for health care entities 6. Regulatory considerations and potential delays for health care transactions Have questions or want to connect with the team? Reach out to us at healthlawdiagnosed@mintz.com.
Show more...
Business
RSS
All content for Health Law Diagnosed is the property of Mintz and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In the latest episode of Health Law Diagnosed, host Bridgette Keller discusses the new Massachusetts Health Care Market Review Law and what this means for health care providers, investors, and other key stakeholders. She is joined by Member Deborah Daccord, Of Counsel, Cassie Paolillo, and Of Counsel Kate Stewart, who share their insights on the law’s far-reaching implications, including: 1. An overview of the Massachusetts Health Care Review Law and its implications 2. Key takeaways for health care entities 3. Upcoming HPC guidance and how it will affect health care transactions 4. Expanded oversight and new authorities for Massachusetts health care agencies 5. Financial assessments for health care entities 6. Regulatory considerations and potential delays for health care transactions Have questions or want to connect with the team? Reach out to us at healthlawdiagnosed@mintz.com.
Show more...
Business
https://i1.sndcdn.com/artworks-1VsgsRvcvEE5cEbB-7EDgLA-t3000x3000.jpg
New Year's Gratitude
Health Law Diagnosed
16 minutes 53 seconds
9 months ago
New Year's Gratitude
In the latest episode of Health Law Diagnosed, host Of Counsel Bridgette Keller invites the Mintz Health Law team to reflect on what they’re grateful for as they prepare for the year ahead. Hear from a dynamic group of Members, Of Counsel, and Associates as they share their perspectives on what’s coming up over the horizon. Have questions or want to connect with the team? Reach out to us at healthlawdiagnosed@mintz.com.
Health Law Diagnosed
In the latest episode of Health Law Diagnosed, host Bridgette Keller discusses the new Massachusetts Health Care Market Review Law and what this means for health care providers, investors, and other key stakeholders. She is joined by Member Deborah Daccord, Of Counsel, Cassie Paolillo, and Of Counsel Kate Stewart, who share their insights on the law’s far-reaching implications, including: 1. An overview of the Massachusetts Health Care Review Law and its implications 2. Key takeaways for health care entities 3. Upcoming HPC guidance and how it will affect health care transactions 4. Expanded oversight and new authorities for Massachusetts health care agencies 5. Financial assessments for health care entities 6. Regulatory considerations and potential delays for health care transactions Have questions or want to connect with the team? Reach out to us at healthlawdiagnosed@mintz.com.